These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9848973)

  • 1. Measles vaccine effectiveness in central Australian aboriginal children vaccinated at or after eight months of age.
    Patel M; Lush D
    Aust N Z J Public Health; 1998 Oct; 22(6):729-30. PubMed ID: 9848973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies.
    Hennessey KA; Ion-Nedelcu N; Craciun MD; Toma F; Wattigney W; Strebel PM
    Am J Epidemiol; 1999 Dec; 150(11):1250-7. PubMed ID: 10588086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles outbreak in a northern Pakistani village: epidemiology and vaccine effectiveness.
    Murray M; Rasmussen Z
    Am J Epidemiol; 2000 Apr; 151(8):811-9. PubMed ID: 10965978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a measles vaccine efficacy during a measles outbreak in Mbare, City of Harare Zimbabwe.
    Mahomva AI; Moyo IM; Mbengeranwa LO
    Cent Afr J Med; 1997 Sep; 43(9):254-6. PubMed ID: 9509644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles outbreak among unvaccinated preschool-aged children: opportunities missed by health care providers to administer measles vaccine.
    Hutchins SS; Escolan J; Markowitz LE; Hawkins C; Kimbler A; Morgan RA; Preblud SR; Orenstein WA
    Pediatrics; 1989 Mar; 83(3):369-74. PubMed ID: 2784000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher risk of measles when the first dose of a 2-dose schedule of measles vaccine is given at 12-14 months versus 15 months of age.
    De Serres G; Boulianne N; Defay F; Brousseau N; Benoît M; Lacoursière S; Guillemette F; Soto J; Ouakki M; Ward BJ; Skowronski DM
    Clin Infect Dis; 2012 Aug; 55(3):394-402. PubMed ID: 22543023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass use of live measles vaccine in aboriginal children in the Northern Territory.
    Langsford WA; Vawser ND
    Med J Aust; 1969 Feb; 1(5):223-5. PubMed ID: 5777901
    [No Abstract]   [Full Text] [Related]  

  • 8. Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age.
    Paunio M; Hedman K; Davidkin I; Valle M; Heinonen OP; Leinikki P; Salmi A; Peltola H
    Epidemiol Infect; 2000 Apr; 124(2):263-71. PubMed ID: 10813152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroconversion after administration of measles vaccine to central Australian Aboriginal children at nine months of age.
    Hanna JN; Macintyre AB; Worswick DA; Burrell CJ
    Med J Aust; 1989 Feb; 150(4):188, 191-2. PubMed ID: 2654583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles vaccine efficacy during an outbreak in a highly vaccinated population: incremental increase in protection with age at vaccination up to 18 months.
    De Serres G; Boulianne N; Meyer F; Ward BJ
    Epidemiol Infect; 1995 Oct; 115(2):315-23. PubMed ID: 7589271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa.
    Whittle HC; Aaby P; Samb B; Jensen H; Bennett J; Simondon F
    Lancet; 1999 Jan; 353(9147):98-102. PubMed ID: 10023894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles outbreak in western Sydney. Vaccine failure or failure to vaccinate?
    McDonnell LF; Jorm LR; Patel MS
    Med J Aust; 1995 May; 162(9):471-5. PubMed ID: 7746203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age.
    Aaby P; Andersen M; Sodemann M; Jakobsen M; Gomes J; Fernandes M
    BMJ; 1993 Nov; 307(6915):1308-11. PubMed ID: 8257884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of measles vaccine during the 1993 measles epidemic in Korea.
    Kim SK; Son BK; Chung CY; Ahn YM; Park CY; Lee HJ
    Pediatr Infect Dis J; 1995 May; 14(5):346-9. PubMed ID: 7638007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of vaccination at 6 to 11 months of age during an outbreak of measles.
    de Serres G; Boulianne N; Ratnam S; Corriveau A
    Pediatrics; 1996 Feb; 97(2):232-5. PubMed ID: 8584383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles vaccine efficacy in children previously vaccinated at 12 months of age.
    Marks JS; Halpin TJ; Orenstein WA
    Pediatrics; 1978 Dec; 62(6):955-60. PubMed ID: 733423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Australian vaccine preventable disease epidemiological review series: measles 2000-2011.
    Chiew M; Dey A; Martin N; Wang H; Davis S; McIntyre PB
    Commun Dis Intell Q Rep; 2015 Mar; 39(1):E1-9. PubMed ID: 26063085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles outbreak in 31 schools: risk factors for vaccine failure and evaluation of a selective revaccination strategy.
    Yuan L
    CMAJ; 1994 Apr; 150(7):1093-8. PubMed ID: 8137189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population.
    Edmonson MB; Addiss DG; McPherson JT; Berg JL; Circo SR; Davis JP
    JAMA; 1990 May; 263(18):2467-71. PubMed ID: 2278542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine.
    Whittle HC; Rowland MG; Mann GF; Lamb WH; Lewis RA
    Lancet; 1984 Oct; 2(8407):834-7. PubMed ID: 6148572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.